MedTrace Logo

Evaluation of Pharmacokinetic and Safety of NVP-2102 and NVP-2102-R in Healthy Subjects

NCT05023031 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2022-01-19

No results posted yet for this study

Summary

The purpose of this study is to compare the pharmacokinetics and safety of NVP-2102 and NVP-2102-R.

Conditions

  • Healthy Subjects

Interventions

DRUG

NVP-2102

Tablet formulation for oral administration, single dose of NVP-2102 at Day 1

DRUG

NVP-2102-R

Tablet formulation for oral administration, single dose of NVP-2102-R at Day 1

Sponsors & Collaborators

  • NVP Healthcare

    lead INDUSTRY

Principal Investigators

  • Jae Woo Kim · H+ Yangji hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-05
Primary Completion
2021-12-24
Completion
2022-01-15

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05023031 on ClinicalTrials.gov